|
|
||||||||
Obstetric Imaging |
1 From the Departments of Obstetrics and Gynaecology (S.M.E.B., J.A.M.L., P.C.S., J.W.W.) and Epidemiology and Biostatistics (T.S.), Erasmus University Medical Centre, University Hospital Rotterdam-Dijkzigt, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands. Received March 22, 2001; revision requested April 26; final revision received November 7; accepted December 5. Address correspondence to J.W.W. (e-mail: breur@gyna.azr.nl).
| ABSTRACT |
|---|
|
|
|---|
MATERIALS AND METHODS: Pregnant women (n = 135) underwent ultrasonography. The coefficient of variation (CV) for hepatic volume scans obtained at 0 and 20 minutes and hepatic area tracings, performed twice for each scan, was determined (n = 20; range, 2336 weeks). Normal data for hepatic volume and head and upper abdominal circumferences were obtained (n = 85; range, 2036 weeks) and related to data from growth-restricted fetuses (birth weight < P5 centile; n = 24; range, 2236 weeks).
RESULTS: CV was 2.9% for volume scans and 1.6% for area tracings. In 85 uncomplicated cases, mean fetal hepatic volume (P50 centile) was 9.7 mL ± 4.4 (SD) at 20 weeks and 96.4 mL ± 8.2 at 36 weeks of gestation. In 24 growth-restricted fetuses, hepatic volume, head circumference, and upper abdominal circumference expressed as percentages of the normal P50 centile were 45%, 90%, and 82%, respectively. Mean difference in hepatic volume between fetal growth restriction and normal fetal development, as expressed with the z score, -4.32 ± 1.4, was significantly different (P < .05) from that for head circumference, -3.04 ± 1.3, but not from that for upper abdominal circumference, -4.7 ± 1.2. Fetal hepatic measurement was obtained in 109 pregnancies.
CONCLUSION: Acceptable reproducibility exists for hepatic volume determinations. In fetal growth restriction, reduction is more pronounced for hepatic volume than for head or upper abdominal circumference; hepatic volume is a better discriminator than head circumference but not upper abdominal circumference.
© RSNA, 2002
Index terms: Abdomen, US, 856.128, 856.12981 Fetus, central nervous system, 856.871 Fetus, gastrointestinal tract, 856.871 Fetus, growth and development, 856.871 Fetus, US, 856.128, 856.12981
| INTRODUCTION |
|---|
|
|
|---|
Recently, a more direct approach to measurement of fetal hepatic volume by using three-dimensional (3D) US was reported (6), including preliminary data on normal fetal hepatic volume from our center (Erasmus University Medical Centre, University Hospital Rotterdam-Dijkzigt, Rotterdam, the Netherlands) (7). To our knowledge, no data are available about 3D US measurement of fetal hepatic volume in fetal growth restriction. Therefore, the purpose of our study was to establish reproducibility and normal values for fetal hepatic volume and its importance in identification of fetal growth restriction relative to head and upper abdominal circumferences according to a cross-sectional study design.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Technically acceptable US hepatic recordings were obtained in 85 of 104 uncomplicated pregnancies and in 24 of 31 pregnancies associated with fetal growth restriction, which resulted in success rates of 82% and 77%, respectively. A US hepatic recording qualified as acceptable if the entire contour of the liver could be manually outlined. Recording failures were mainly due to maternal obesity, fetal position, or excessive fetal movement. A hepatic volume calculation took approximately 15 minutes. Each woman underwent evaluation only once in the study.
An uncomplicated pregnancy constituted the delivery of a healthy neonate with a birth weight between the 5th and 95th centile for weight of gestation, according to the Kloosterman tables (8). Fetal growth restriction was represented by fetal upper abdominal circumference below the 5th centile (9), and a birth weight below the 5th centile for weight of gestation was confirmed after delivery, according to the Kloosterman tables (8).
Pregnancy duration was determined from last menstruation and confirmed by means of US before 20 weeks of gestation. Gestation was at 2036 weeks (median, 30 weeks) in uncomplicated pregnancies and 2236 weeks (median, 29 weeks) in the subset of pregnancies with fetal growth restriction. Maternal age in all 109 pregnancies was 1942 years (median, 29 years).
The 5-MHz annular array transducer (VSW 35; Kretz Technik, Zipf, Austria) of the US machine (Combison 530-D; Kretz Technik) was used for volume scanning. Two examiners (S.M.E.B. and J.A.M.L.) obtained the data and hepatic volume measurements.
Organ volumes were determined by slicing through collected images and recording a truncated pyramidal volume. Depth, longitudinal, and transverse dimensions of this volume were adjustable, with an initial area of 6.6 x 3.3 cm, up to a maximum area of 28 x 22 cm at a depth of 20 cm. These dimensions provide a maximum scanned volume of 5.9 L. The maximum resolution in the longitudinal direction was 512 ultrasound lines for each of the maximum of 500 sections in the transverse, or sweep, direction.
In the present study, the opening angle of each plane was 70°, and the angle of the volume sample was limited to a maximum of 60°. The depth of the volume was restricted to 1216 cm, with a resolution of 210 sections per volume. After each US scan, the volume was presented in three perpendicular planes on the monitor and represented frontal, sagittal, and transverse cross sections of the fetus. Data were stored on hard disk (Iomega Jaz Drive; Iomega, Roy, Utah) for off-line analysis.
In a first step toward fetal hepatic volume determination, a frontal cross section of the liver anterior to the stomach was visualized. In a simultaneously demonstrated sagittal cross section, the outline of the liver was traced manually in approximately 10 sagittal sections between the most lateral left and right points of the diaphragm in the frontal plane. The liver was measured from its upper limit at the diaphragm to its lower limit at the distal rim. The system automatically kept track of the distances between the sections and calculated the total volume after each area measurement was completed.
In each instance, fetal hepatic volume recording was followed by measurement of fetal head and upper abdominal circumferences and femur length. Fetal weight was estimated from these biometric parameters by using the Hadlock formula (10).
Reproducibility
The first 20 uncomplicated singleton pregnancies examined by S.M.E.B. were enrolled in the reproducibility study. Pregnancy duration was at 2336 weeks of gestation. Hepatic volume recordings were obtained at 0 and 20 minutes to determine the intraobserver variability as expressed by means of the coefficient of variation (CV). To establish the CV for fetal hepatic volume tracings, the tracings were performed twice for each hepatic volume recordingthe one obtained at 0 minutes and the one obtained at 20 minutes. Analysis of variance was used to calculate the variance and the SD within the separate categories of recordings and tracings. The CV was calculated by dividing the SD by the overall mean of the measurements.
Statistics
The gestational agerelated reference centilesP5, P50, and P95were constructed by using the method described by Altman (11). According to this procedure, we modeled the relationships among hepatic volume, head circumference, upper abdominal circumference, and gestational age by means of a cubic polynomial. Either the linear or quadratic term was left out because of too low a tolerance (SPSS version 8.0 for Windows; SPSS, Chicago, Ill). The age-specific SD was obtained from linear regression of the absolute residuals on gestational age. Polynomial linear regression was used to calculate the relationship between hepatic volume and estimated fetal weight.
Data from hepatic volume, head circumference, and upper abdominal circumference for fetal growth restriction were expressed as ratios. Every observed value of the growth-restricted fetus was divided by the corresponding normal P50 value for gestational age. Abdominal circumference and head circumference ratios were raised to the power of three to estimate the abdominal and head volume reduction in growth-restricted fetuses. These values were compared with the 3D hepatic volume data for fetal growth restriction.
Mean difference in hepatic volume between fetuses with growth restriction and those with normal development was determined with the z score, which was calculated as follows: z score = hepatic volumeFGR - P50normal/SDnormal, where FGR represents fetuses with growth restriction and "normal" represents fetuses with normal development. In the group with fetal growth restriction, the percentage of normal P50 values and z scores of the hepatic volume were compared with upper abdominal and head circumference values by means of the paired sample t test. The level of statistical significance was set at .05.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
Mean difference in hepatic volume between fetuses with growth restriction and those with normal development as expressed by means of percentage of the normal P50 values was 45% ± 13.0, which is significantly different (P < .001) from head circumference, 90% ± 4.2, and fetal upper abdominal circumference, 82% ± 4.1. Within the subset of growth-restricted fetuses, mean hepatic volume was also significantly smaller (P < .001) than the estimated head volume of 75% ± 11 and estimated abdominal volume of 56% ± 8.4. Mean difference in hepatic volume between fetuses with growth restriction and those with normal development, as expressed with the z score, was -4.32 ± 1.4, which is significantly different (P < .05) from the z score for head circumference, -3.04 ± 1.3, but not that for fetal upper abdominal circumference, -4.7 ± 1.2.
| DISCUSSION |
|---|
|
|
|---|
Low image quality occurred in the presence of maternal obesity or when the fetal back was in the anterior position. In the latter case, fetal bones, particularly vertebrae and ribs, caused shadows on some parts of the fetal abdomen, which limited the definition of some sections inside the volume box. Reduced amniotic fluid volume constituted a reason for not obtaining a technically acceptable hepatic volume measurement in the growth-restricted fetus. In the present study, the second half of pregnancy was not selected because of 3D hepatic volume measurement limitation before 20 weeks of gestation (6) but because fetal growth restriction usually does not begin until 2224 weeks of gestation.
Acceptable reproducibility of hepatic volume measurements is essential before embarking on a clinical study. We demonstrated that the reproducibility of fetal hepatic volume recordings and tracings is good, with a total CV less than 4%. We did not study the accuracy of fetal hepatic volume measurements with 3D US, but other investigations (1214) have been performed to confirm the accuracy of 3D US volume measurements.
In uncomplicated pregnancies, fetal hepatic volume demonstrates a tenfold increase with advancing gestational age and increasing fetal weight. The regression line, shown in Figure 4, demonstrates that the hepatic volume is proportional to estimated fetal weight during the second half of pregnancy.
Currently, US measurement of fetal head and upper abdominal circumferences is the most widely used method of establishing impaired fetal growth (15,16). The detection of fetal growth restriction by means of head circumference measurements may be limited because of fetal brain sparing in the presence of chronic fetal hypoxemia. Results of a majority of studies (15,16) have shown that the most effective method of detecting fetal growth restriction is measurement of the upper abdominal circumference. However, this measurement is not satisfactory because the positive predictive value for detecting fetal growth restriction may be as low as 21% (17). Therefore, accurate assessment of hepatic volume may contribute to the early detection of growth-restricted fetuses, since hepatic weight in these fetuses is reduced due to reduction in hepatic glycogen stores (3).
Fetal hepatic volume has been estimated indirectly through measurement of hepatic length, circumference, and area by using two-dimensional US (18,19) and more recently by using 3D US. A linear relationship has been described between two-dimensional fetal hepatic length and fetal upper abdominal circumference in uncomplicated pregnancies (18,19). Three-dimensional US measurements of the normal hepatic volume demonstrated a close linear relation between hepatic volume and estimated fetal weight (6,7). Baker et al (17) were able to show that fetal hepatic volume measurements obtained with magnetic resonance (MR) imaging allowed accurate detection of fetuses that were subsequently found to be growth restricted. However, MR imaging is associated with reduced patient acceptability and high cost.
The present study results show that fetal growth restriction is associated with reduced hepatic volume in every instance. Moreover, when expressed as a percentage of the normal P50, the decrease in hepatic volume is more pronounced than is the reduction in head circumference or upper abdominal circumference. When looking at the mean difference in hepatic volume between normal and reduced fetal growth, as expressed with the z score, we found a significant difference only when comparing these values with head circumference, which confirms the brain-sparing effect during abnormal fetal development.
Three-dimensional US measurements of fetal hepatic volume show good reproducibility. Normal fetal hepatic volume is tenfold larger at the end of gestation, as compared with that at the beginning of the second half of pregnancy. Fetal growth restriction affects fetal size, but fetal hepatic volume measurement is not a better discriminator for growth restriction than is upper abdominal circumference measurement.
| FOOTNOTES |
|---|
Abbreviations: CV = coefficient of variation 3D = three-dimensional
Author contributions: Guarantor of integrity of entire study, J.W.W.; study concepts, S.M.E.B., J.W.W., P.C.S.; study design, T.S., J.A.M.L.; literature research, S.M.E.B.; clinical studies, S.M.E.B., J.A.M.L.; data acquisition, S.M.E.B., J.A.M.L.; data analysis/interpretation, S.M.E.B., P.C.S., J.A.M.L.; statistical analysis, S.M.E.B., T.S., P.C.S.; manuscript preparation, S.M.E.B., P.C.S., J.A.M.L., J.W.W.; manuscript definition of intellectual content and editing, J.W.W., T.S.; manuscript revision/review, S.M.E.B., J.W.W.; manuscript final version approval, J.W.W.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. H. van den Akker, H. Schierbeek, T. Rietveld, A. Vermes, J. J Duvekot, E. A. Steegers, and J. B van Goudoever Human fetal albumin synthesis rates during different periods of gestation Am. J. Clinical Nutrition, October 1, 2008; 88(4): 997 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Chen, E. M. Simon, J. C. Haselgrove, L. T. Bilaniuk, L. N. Sutton, M. P. Johnson, D. M. Shera, and R. A. Zimmerman Fetal Posterior Fossa Volume: Assessment with MR Imaging Radiology, March 1, 2006; 238(3): 997 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Bhat, V. Corbett, N. Carpenter, N. Liu, R. Liu, A. Wu, G. Hopkins, R. Sohaey, C. Winkler, C. S. Sahn, et al. Fetal Ventricular Mass Determination on Three-Dimensional Echocardiography: Studies in Normal Fetuses and Validation Experiments Circulation, August 31, 2004; 110(9): 1054 - 1060. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |